| Overview |
| bsm-61682r-Cy5.5-100ul |
| WDR5 Recombinant Antibody, Cy5.5 Conjugated |
| FCM, IF(IHC-P) |
| Human, Mouse, Rat |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human WDR5 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 11091 |
| P61964 |
| BIG3; SWD3; Wdr5. |
| Contributes to histone modification. May position the N-terminus of histone H3 for efficient trimethylation at 'Lys-4'. As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. |
| Application Dilution |
| FCM |
1:50-100 |
| IF(IHC-P) |
IFIHC-P1:100-500 |
Powered by Bioz